Therapeutic potential of semi-mature dendritic cells for tolerance induction.
about
Dendritic Cells: A Double-Edged Sword in Immune Responses during Chagas DiseaseDendritic Cell-based Immunotherapy for Rheumatoid Arthritis: from Bench to BedsideMolecular Mechanisms of Induction of Tolerant and Tolerogenic Intestinal Dendritic Cells in MiceTherapeutic Potential of Hyporesponsive CD4(+) T Cells in AutoimmunityRole of the immunogenic and tolerogenic subsets of dendritic cells in multiple sclerosisRegulatory dendritic cells: there is more than just immune activationInhibition of breast cancer resistance protein (ABCG2) in human myeloid dendritic cells induces potent tolerogenic functions during LPS stimulationUnconventional maturation of dendritic cells induced by particles from the laminated layer of larval Echinococcus granulosusElevated levels of dehydroepiandrosterone as a potential mechanism of dendritic cell impairment during pregnancy.Silenced suppressor of cytokine signaling 1 (SOCS1) enhances the maturation and antifungal immunity of dendritic cells in response to Candida albicans in vitroPeripheral Dendritic Cells and CD4+CD25+Foxp3+ Regulatory T Cells in the First Trimester of Normal Pregnancy and in Women with Recurrent Miscarriage.Tolerogenic dendritic cells and their applications in transplantationStaphylococcus aureus phenol-soluble modulin peptides modulate dendritic cell functions and increase in vitro priming of regulatory T cells.It's time to bring dendritic cell therapy to type 1 diabetes.Stromal cell induction of regulatory dendritic cells.MicroRNA profiling of activated and tolerogenic human dendritic cellsTolerogenic dendritic cell therapy in organ transplantation.Overcoming immunological barriers in regenerative medicine.Targeting of tolerogenic dendritic cells towards heat shock proteins: a novel therapeutic strategy for autoimmune diseases?Low doses of cholera toxin and its mediator cAMP induce CTLA-2 secretion by dendritic cells to enhance regulatory T cell conversion.Treatment with Dexamethasone and Monophosphoryl Lipid A Removes Disease-Associated Transcriptional Signatures in Monocyte-Derived Dendritic Cells from Rheumatoid Arthritis Patients and Confers Tolerogenic Features.Dendritic cells treated with chloroquine modulate experimental autoimmune encephalomyelitis.Lactic acid bacteria strains exert immunostimulatory effect on H. pylori-induced dendritic cells.Inflammatory conditions distinctively alter immunological functions of Langerhans-like cells and dendritic cells in vitro.Translating Tolerogenic Therapies to the Clinic - Where Do We Stand and What are the Barriers?Trichinella spiralis Excretory-Secretory Products Induce Tolerogenic Properties in Human Dendritic Cells via Toll-Like Receptors 2 and 4.DOCK2 is critical for CD8(+) TCR(-) graft facilitating cells to enhance engraftment of hematopoietic stem and progenitor cells.Targeting DEC-205−DCIR2+ dendritic cells promotes immunological tolerance in proteolipid protein-induced experimental autoimmune encephalomyelitis.Mechanisms underlying immune tolerance caused by recombinant Echinococcus granulosus antigens Eg mMDH and Eg10 in dendritic cells
P2860
Q26740647-4F6126EE-A517-415A-8574-E682744DDC83Q26764858-B1E8B878-D0F8-49EE-A850-9BBCEF801DEAQ26765030-5DF0F4C2-EBCD-48C4-A6C4-2F69B847D8B8Q26781243-2CE3C577-8746-485C-99FF-D3AFE26DCF42Q28082878-FC6D3A51-A2BB-4429-B955-5D04C479B7E7Q28388235-D8D01C31-D158-43DD-8EF8-62CC403B0363Q34027988-16DC40FC-EFB1-4B89-A553-A69D9756E661Q34058933-5C67B57E-0C12-40E0-BA79-766A2BAD7E46Q35066759-89DAAF69-7110-418C-8FEC-8DEDB8F273D4Q35108316-6046A31E-F796-4DC4-97EF-F24B5F96FAA5Q35577641-955ED70E-843C-40C1-B886-72492DEB27F2Q36302853-5035754F-C99D-4B93-9F05-09340FFA7E80Q36718021-58B30FA8-85BE-4CC4-B4F6-DE673D96CCA7Q37670174-7E783DAD-AA5B-48AF-BBB7-3BA855E1A018Q38039093-47324322-538B-4A3B-8500-DF9FB79461B6Q38889224-4D662A21-303A-4360-8EDC-148AD22A5B68Q39013872-16D08714-3247-4D49-A65D-F9D23472EC91Q39948888-AB080603-8FE8-41A6-BAE1-1DBF6DF4987AQ40095092-CBF609F9-076A-498A-BF4C-8D9AF99A5C40Q40101283-2CC470A2-DA01-4C0E-AFC7-42630DA103F3Q41563600-876679E6-28E0-4CF8-BB14-DADF4659F79BQ41923517-2A16A21E-9E92-4774-96F3-A76D94CCD7D7Q42002775-34ECBBB8-804E-4122-8B41-D1A6A8F98623Q42203982-283D6936-95D3-4A7F-B8CA-A1CABA5CD71FQ42428575-8C37D18E-7ED7-47B1-A906-6147A7E246A8Q49376559-FA5A2233-949D-4339-BC3A-230C0D0C6A41Q53033188-601A4F8A-D250-419B-AD9F-E39A949D4E4BQ55502642-009351C4-188A-42D4-ABD6-042B805C62A2Q59129282-B306A8A7-AA4D-4716-8A83-3F5B37EB5A3A
P2860
Therapeutic potential of semi-mature dendritic cells for tolerance induction.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Therapeutic potential of semi-mature dendritic cells for tolerance induction.
@en
Therapeutic potential of semi-mature dendritic cells for tolerance induction.
@nl
type
label
Therapeutic potential of semi-mature dendritic cells for tolerance induction.
@en
Therapeutic potential of semi-mature dendritic cells for tolerance induction.
@nl
prefLabel
Therapeutic potential of semi-mature dendritic cells for tolerance induction.
@en
Therapeutic potential of semi-mature dendritic cells for tolerance induction.
@nl
P2860
P356
P1476
Therapeutic potential of semi-mature dendritic cells for tolerance induction.
@en
P2093
Manfred B Lutz
P2860
P356
10.3389/FIMMU.2012.00123
P577
2012-05-18T00:00:00Z